Denmark· DK-28106183118
Spravato
A esketamine product containing esketaminhydrochlorid, registered in Denmark by Janssen-Cilag International NV. The same ATC class is registered in 11 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Esketamine is registered in 11 of 19 countries.
Countries holding a registration under ATC N06AX27 (esketamine), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 7 of them publish a price we can compare per daily dose
Esketamine · ATC N06AX27
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of esketamine costs, country by country.
Normalised to the WHO defined daily dose (8 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Esketamine · price per daily dose (8 mg)
USD · FX 28 Sept 2026
- CH Switzerland$66.47
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Esketaminhydrochlorid
- Manufacturer
- Janssen-Cilag International NV
- Country
- Denmark (DK)
- ATC code
- N06AX27
- ATC class
- Esketamine
- Defined daily dose
- 8 mg, N
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106183118
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
91 interactions on record for esketamine.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Esketamine · interactions on record
91 records
- 7 severe
- 84 moderate
Most severe, free to view
- PhentermineA08AA01severe
- FenfluramineA08AA02severe
- MazindolA08AA05severe
- FenfluramineN03AX26severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N06AX27
Esketamine, as other registers publish it.
- PolandSpravatoJanssen-Cilag International N.V.
- FinlandSpravatoJanssen-Cilag International NV
- IcelandSpravatoJanssen-Cilag International NV*
- NorwaySpravatoJanssen-Cilag International N.V.
- CzechiaSPRAVATOJanssen-Cilag International N.V., Beerse
- CzechiaSPRAVATOJanssen-Cilag International N.V., Beerse
- CzechiaSPRAVATOJanssen-Cilag International N.V., Beerse
- CzechiaSPRAVATOJanssen-Cilag International N.V., Beerse
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/067150b2-95d6-4328-8e49-6ed4a5914bee GET /v1/drugs/067150b2-95d6-4328-8e49-6ed4a5914bee?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "næsespray, opløsning",
"source": "dkma",
"strength": "28 mg",
"auth_role": "MOD",
"dk_drugid": "28106183118",
"substance": "Esketaminhydrochlorid",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "43817"
}See everything about esketamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.